Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials

Detalles Bibliográficos
Autores principales: Bachert, Claus, Corren, Jonathan, Lee, Stella E., Zhang, Haixin, Harel, Sivan, Cunoosamy, Danen, Khan, Asif H., Jacob‐Nara, Juby A., Siddiqui, Shahid, Nash, Scott, Rowe, Paul J., Deniz, Yamo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Notes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544911/
https://www.ncbi.nlm.nih.gov/pubmed/34970860
http://dx.doi.org/10.1002/alr.22964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544911/
https://www.ncbi.nlm.nih.gov/pubmed/34970860
http://dx.doi.org/10.1002/alr.22964

Ejemplares similares